Loading
RM
REVA Medical, Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Stockman Robert Bernard, was filed 14 Nov 2019.
REVA Medical, Inc.: what insiders have been doing
REVA Medical, Inc. is a listed company. Filings by its managers are published through SEC (Form 4). No insider at REVA Medical, Inc. has published a filing in the past twelve months. The most recent one dates from 14 November 2019.
Our records for REVA Medical, Inc. go back to 2016, with 26 purchases and 6 sales on the open market in total.
This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Insider Decl.
55
Thresholds
n/a
Buy Volume
€725,365
26 ops. · all time
Sell Volume
€334,916
6 ops. · all time
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Last declaration on 14 November 2019
Declarations55 total
372,218.8 shares@ US$0.00030.2% of flowCommon StockSEC:0001209191-19-056549:0
Canonical exit: 9 Feb 2020 (T+90)
15,500 sharesCommon StockSEC:0000904454-19-000712:0
15,500 sharesCommon StockSEC:0000904454-19-000712:1
3,606,002 sharesCommon StockSEC:0000904454-19-000712:2
85,186 sharesCommon StockSEC:0000904454-19-000712:3
3,000 shares0Common StockSEC:0000904454-18-000449:0
3,000 shares0Common StockSEC:0000904454-18-000449:1
16,359.6 shares@ US$1.5334.6% of flowCommon StockSEC:0001209191-18-040517:0
Canonical exit: 27 Sept 2018 (T+90)
19,631.5 shares@ US$1.53100.0% of flowCommon StockSEC:0001209191-18-040515:0
Canonical exit: 27 Sept 2018 (T+90)
3,271.9 shares@ US$1.53100.0% of flowCommon StockSEC:0001209191-18-040513:0
Canonical exit: 27 Sept 2018 (T+90)
9,815.7 shares@ US$1.53100.0% of flowCommon StockSEC:0001209191-18-040511:0
Canonical exit: 27 Sept 2018 (T+90)
4,907.9 shares@ US$1.53100.0% of flowCommon StockSEC:0001209191-18-040512:0
Canonical exit: 27 Sept 2018 (T+90)
16,359.6 shares@ US$1.53100.0% of flowCommon StockSEC:0001209191-18-040516:0
Canonical exit: 27 Sept 2018 (T+90)
32,719.1 shares@ US$1.5349.4% of flowCommon StockSEC:0001209191-18-040514:0
Canonical exit: 27 Sept 2018 (T+90)
2,500 shares@ US$1.866.3% of flowCommon StockSEC:0001209191-18-038213:0
Canonical exit: 11 Sept 2018 (T+90)
2,500 shares@ US$1.746.0% of flowCommon StockSEC:0001209191-18-038213:1
Canonical exit: 12 Sept 2018 (T+90)
2,000 shares@ US$2.06Common StockSEC:0001209191-18-034888:0
Canonical exit: 28 Aug 2018 (T+90)
3,000 shares@ US$2.08Common StockSEC:0001209191-18-034888:1
Canonical exit: 29 Aug 2018 (T+90)
114,000 shares0Common Stock (RSUs)SEC:0001209191-18-031614:0
5,000 shares@ US$2.99Common StockSEC:0001209191-18-022214:0
Canonical exit: 26 Jun 2018 (T+90)
5,000 shares@ US$3.02Common StockSEC:0001209191-18-021992:0
Canonical exit: 25 Jun 2018 (T+90)
32,000 shares0Common Stock (RSUs)SEC:0001209191-18-005009:0
32,000 shares0Common Stock (RSUs)SEC:0001209191-18-005010:0
50,000 shares0Common Stock (RSUs)SEC:0001209191-18-005011:0
10,300 shares@ US$5.13Common StockSEC:0001209191-18-003461:0
Canonical exit: 29 Mar 2018 (T+90)
25 of 55 declarations
About REVA Medical, Inc.
REVA Medical, Inc. is a company focused on developing medical devices for the treatment of cardiovascular diseases. It is listed on the XNAS market.
